Street Calls of the Week
Investing.com - TD Cowen has upgraded Delek US (NYSE:DK) from Sell to Hold and significantly raised its price target to $28.00 from $15.00. The stock, which has surged 81.6% year-to-date and is trading near its 52-week high of $32.61, appears overvalued according to InvestingPro analysis.
The rating change reflects Delek’s award of small refinery exemptions (SREs), which TD Cowen believes will add an estimated minimum of $150 million per year in EBITDA to the company.
The investment firm expressed "reasonable confidence" that similar exemptions will continue at least through 2027, providing a sustained financial benefit to the refiner.
TD Cowen also noted that Delek is expected to benefit from changes in the crude market structure as it flips to contango, a market condition where future prices are higher than current prices.
The new price target of $28.00 represents an 87% increase from the previous target of $15.00, reflecting the firm’s more positive outlook on Delek’s financial prospects.
In other recent news, Delek US Energy Inc. reported its Q2 2025 earnings, revealing a narrower-than-expected loss. The company posted an adjusted EPS of -$0.56, beating the forecast of -$0.86. Revenue for the quarter reached $2.76 billion, exceeding analysts’ expectations of $2.67 billion. Despite these positive results, the stock saw a decline in pre-market trading. Additionally, Wolfe Research has upgraded Delek US from Peerperform to Outperform. The research firm set a price target of $40.00, citing benefits from SRE. This upgrade reflects Delek US’s strong performance, as its stock has gained 68% year-to-date.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.